NeuroUX shared a post on LinkedIn:
“New paper alert!
This study demonstrates the feasibility, reliability, and validity of NeuroUX‘s mobile cognitive tests for evaluating cancer-related cognitive impairments in breast cancer survivors.
Over an 8-week period, participants completed smartphone-based cognitive tests with high adherence (87.3%) and high satisfaction (mean 87%). These findings highlight the value of NeuroUX for real-world cognitive monitoring in oncology.
Congratulations to the research team on this important work!
Read the full paper here.”
Authors: Ashley M. Henneghan et al.
